Stock & Company Details
Galectin Therapeutics Inc $GALT
Price:
N/A
N/A
101M
$418M
52 Week High:
N/A
10 Day Average Volume:
N/A
-9.86
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GALT technical indicators
Latest Galectin Therapeutics Inc (GALT) indicator readings as of 2026-08-28.
GALT's 14-day RSI is 59.8, in neutral territory. At $4.02 it is trading 15.6% above its 200-day moving average of $3.48, and above its 50-day average of $3.81. Price sits near the upper Bollinger Band ($2.78 to $4.25). ADX reads 22.4, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Finance Bot
Ask your questions
Start by typing a question below.
